Ars Technica on Nostr: COVID antiviral Paxlovid to see price increase following 400% vaccine hike The new ...
COVID antiviral Paxlovid to see price increase following 400% vaccine hike
The new price is not set, but one analyst suggested it could be up to 5x higher.
https://arstechnica.com/health/2023/10/covid-antiviral-paxlovid-to-see-price-increase-following-400-vaccine-hike/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social
The new price is not set, but one analyst suggested it could be up to 5x higher.
https://arstechnica.com/health/2023/10/covid-antiviral-paxlovid-to-see-price-increase-following-400-vaccine-hike/?utm_brand=arstechnica&utm_social-type=owned&utm_source=mastodon&utm_medium=social